These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28185567)

  • 1. From comorbidities of chronic obstructive pulmonary disease to identification of shared molecular mechanisms by data integration.
    Gomez-Cabrero D; Menche J; Vargas C; Cano I; Maier D; Barabási AL; Tegnér J; Roca J;
    BMC Bioinformatics; 2016 Nov; 17(Suppl 15):441. PubMed ID: 28185567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort.
    Chubachi S; Sato M; Kameyama N; Tsutsumi A; Sasaki M; Tateno H; Nakamura H; Asano K; Betsuyaku T;
    Respir Med; 2016 Aug; 117():272-9. PubMed ID: 27492541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
    Vanfleteren LE; Spruit MA; Groenen M; Gaffron S; van Empel VP; Bruijnzeel PL; Rutten EP; Op 't Roodt J; Wouters EF; Franssen FM
    Am J Respir Crit Care Med; 2013 Apr; 187(7):728-35. PubMed ID: 23392440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Obstructive Pulmonary Disease (COPD) as a disease of early aging: Evidence from the EpiChron Cohort.
    Divo MJ; Celli BR; Poblador-Plou B; Calderón-Larrañaga A; de-Torres JP; Gimeno-Feliu LA; Bertó J; Zulueta JJ; Casanova C; Pinto-Plata VM; Cabrera-Lopez C; Polverino F; Carmona Píréz J; Prados-Torres A; Marin JM;
    PLoS One; 2018; 13(2):e0193143. PubMed ID: 29470502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Obstructive Pulmonary Disease heterogeneity: challenges for health risk assessment, stratification and management.
    Roca J; Vargas C; Cano I; Selivanov V; Barreiro E; Maier D; Falciani F; Wagner P; Cascante M; Garcia-Aymerich J; Kalko S; De Mas I; Tegnér J; Escarrabill J; Agustí A; Gomez-Cabrero D;
    J Transl Med; 2014 Nov; 12 Suppl 2(Suppl 2):S3. PubMed ID: 25472887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COPD and its comorbidities: Impact, measurement and mechanisms.
    Negewo NA; Gibson PG; McDonald VM
    Respirology; 2015 Nov; 20(8):1160-71. PubMed ID: 26374280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network medicine analysis of COPD multimorbidities.
    Grosdidier S; Ferrer A; Faner R; Piñero J; Roca J; Cosío B; Agustí A; Gea J; Sanz F; Furlong LI
    Respir Res; 2014 Sep; 15(1):111. PubMed ID: 25248857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer - a comorbidity in chronic obstructive pulmonary disease.
    Roca M; Roca IC; Mihăescu T
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1055-62. PubMed ID: 23700888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic obstructive pulmonary disease and comorbidity: a review and consideration of pathophysiology.
    Tan SL; Wood AM
    Panminerva Med; 2009 Jun; 51(2):81-93. PubMed ID: 19776710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive medicine: outcomes, challenges and opportunities in the Synergy-COPD project.
    Miralles F; Gomez-Cabrero D; Lluch-Ariet M; Tegnér J; Cascante M; Roca J;
    J Transl Med; 2014 Nov; 12 Suppl 2(Suppl 2):S12. PubMed ID: 25472742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and clinical diseasome of comorbidities in exacerbated COPD patients.
    Faner R; Gutiérrez-Sacristán A; Castro-Acosta A; Grosdidier S; Gan W; Sánchez-Mayor M; Lopez-Campos JL; Pozo-Rodriguez F; Sanz F; Mannino D; Furlong LI; Agusti A
    Eur Respir J; 2015 Oct; 46(4):1001-10. PubMed ID: 26250499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease and its comorbidities.
    Panetta NL; Krachman S; Chatila WM
    Panminerva Med; 2009 Jun; 51(2):115-23. PubMed ID: 19776712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chronic obstructive pulmonary disease comorbidity spectrum in Japan differs from that in western countries.
    Takahashi S; Betsuyaku T
    Respir Investig; 2015 Nov; 53(6):259-70. PubMed ID: 26521103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The COPD Knowledge Base: enabling data analysis and computational simulation in translational COPD research.
    Cano I; Tényi Á; Schueller C; Wolff M; Huertas Migueláñez MM; Gomez-Cabrero D; Antczak P; Roca J; Cascante M; Falciani F; Maier D
    J Transl Med; 2014 Nov; 12 Suppl 2(Suppl 2):S6. PubMed ID: 25471253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey.
    Griffo R; Spanevello A; Temporelli PL; Faggiano P; Carone M; Magni G; Ambrosino N; Tavazzi L;
    Eur J Prev Cardiol; 2017 Apr; 24(6):567-576. PubMed ID: 28067533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of comorbidities on COPD assessment: a pilot study.
    Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
    Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.
    Putcha N; Drummond MB; Wise RA; Hansel NN
    Semin Respir Crit Care Med; 2015 Aug; 36(4):575-91. PubMed ID: 26238643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing comorbidity in COPD: a difficult task.
    Tsiligianni IG; Kosmas E; Van der Molen T; Tzanakis N
    Curr Drug Targets; 2013 Feb; 14(2):158-76. PubMed ID: 23256716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common geriatric conditions and disabilities in older persons with chronic obstructive pulmonary disease.
    Landi F; Pistelli R; Abbatecola AM; Barillaro C; Brandi V; Lattanzio F
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S29-34. PubMed ID: 22209927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The progression of comorbidity in IL-18 transgenic chronic obstructive pulmonary disease mice model.
    Takenaka S; Kawayama T; Imaoka H; Sakazaki Y; Oda H; Kaku Y; Matsuoka M; Okamoto M; Kato S; Yamada K; Hoshino T
    Biochem Biophys Res Commun; 2014 Mar; 445(3):597-601. PubMed ID: 24565845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.